Neulasta

Neulasta is a medicine authorised by Swissmedic under authorisation number 56326. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 01 September 2003 and the authorisation is valid without a time limit. ATC code L03AA13 places the medicine in the group Immunostimulants.

  • Dispensing category A
  • Authorisation number 56326
  • ATC L03AA13
  • Biotechnological medicines
Authorisation data
Authorisation number56326
NameNeulasta
Full nameNeulasta, Injektionslösung in einer Fertigspritze
Authorisation holderAmgen Switzerland AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL03AA13
First authorisation01 September 2003
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Neulasta, Injektionslösung in einer FertigspritzeA01 September 2003

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
41Spritze(n)L03AA1306.07.3.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Neulasta authorised in Switzerland?

Yes. Neulasta is authorised by Swissmedic under authorisation number 56326, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Neulasta have?

Neulasta is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Neulasta?

The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com